RxDoctor Payments Data

Cristelle Boots, OD

Optometrist · Blaine, MNNPI 1699323162

Payments from drug & device makers

$229in general payments, 2019–2025

Across 9 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$79
  • Dompe US, Inc.$48
  • Sun Pharmaceutical Industries Inc.$29
  • Biotissue Holdings Inc.$23
  • Tarsus Pharmaceuticals, Inc.$15
  • Johnson & Johnson Vision Care, Inc.$12
  • plus $23 from 2 others

What the payments were for

  • Food & beverage$229100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$229 in reported general payments places this provider in the 45th percentile of 826 optometrist providers in Minnesota.

See all optometrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$42,601
Medicare patients
247
Services billed
537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine53$90,042
XiidraLifitegrast40$60,566
Cyclosporine65$41,655
MieboPerfluorohexyloctane/Pf20$14,845
LumiganBimatoprost12$7,040
RhopressaNetarsudil Mesylate13$5,861
Prednisolone Acetate121$5,384
Fluorometholone31$2,268
Latanoprost120$2,030
Timolol Maleate59$1,075
ErythromycinErythromycin Base78$820
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat29$699
Brimonidine Tartrate27$670
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha53$635
Ketorolac Tromethamine14$357

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan$12$97,08365 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 826 optometrist providers in Minnesota.

Other optometrist in Blaine

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →